XML 32 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE OF FINANCIAL INSTRUMENTS
3 Months Ended
Sep. 30, 2012
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS
5. FAIR VALUE OF FINANCIAL INSTRUMENTS
 
In accordance with the fair value hierarchy described in Note 2, the following table shows the fair value of the Company’s financial instruments that are required to be measured at fair value as of September 30, 2012 and June 30, 2012:
 
September 30, 2012
 
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash equivalents
  $ 158,092     $ -     $ -     $ 158,092  
Common stock warrant liability, warrants exercisable at $2.6058 from September 18, 2011 through September 18, 2016
  $ -     $ -     $ 455,299     $ 455,299  
Common stock warrant liability, warrants exercisable at $5.90 through September 14, 2013
  $ -     $ -     $ 134     $ 134  
                                 
 June 30, 2012
 
Level 1
   
Level 2
   
Level 3
   
Total
 
                                 
Cash equivalents
  $ 141,107     $ -     $ -     $ 141,107  
Common stock warrant liability, warrants exercisable at $2.6058 from September 18, 2011 through September 18, 2016
  $ -     $ -     $ 917,440     $ 917,440  
Common stock warrant liability, warrants exercisable at $5.90 through September 14, 2013
  $ -     $ -     $ 1,126     $ 1,126  
 
 
As of September 30, 2012 and June 30, 2012, the fair values of the Company’s Level 1 financial instruments were $158,092 and $141,107, respectively. These financial instruments consist of cash equivalents, including certificates of deposit and money market accounts. As of September 30, 2012 and June 30, 2012, the Company held no Level 2 financial instruments.
 
As of September 30, 2012 and June 30, 2012, the fair values of the Company’s Level 3 financial instruments totaled $455,433 and $918,566, respectively. The Level 3 financial instruments consist of common stock warrants issued by the Company in March 2011 and March 2007, which include features requiring liability treatment of the warrants. The fair value of warrants issued in March 2011 to purchase 3.9 million shares of the Company’s common stock is based on valuations performed by an independent third party valuation firm. The fair value was determined using proprietary valuation models using the quality of the underlying securities of the warrants, restrictions on the warrants and security underlying the warrants, time restrictions and precedent sale transactions completed in the secondary market or in other private transactions. As of September 30, 2012, the fair value of warrants issued in March 2007 to purchase 903,955 shares of the Company’s common stock was estimated by the Company to be $134 using the Black-Scholes with the following assumptions: dividend yield of 0%, expected stock price volatility of 0.68, risk free interest rate of 0.17%, and an expected life of one year. There were no transfers of assets or liabilities between level 1, level 2, or level 3 during the periods ending September 30, 2012 and June 30, 2012.
 
The following table summarizes the changes in fair value of the Company’s Level 3 financial instruments for the three months ended September 30, 2012 and 2011:
 
   
Three months ended
 
   
September 30,
 
   
2012
   
2011
 
   
(unaudited)
   
(unaudited)
 
Balance, Beginning of period
$ (918,566 )   $ (2,732,253 )
Purchase, sales, issuance, settlements, or transfers
    -       -  
Gain due to change in fair value of warrant liabilities, net
    463,133       1,736,609  
Ending balance
  $ (455,433 )   $ (995,644 )